Need help finding what you are looking for?
Contact Us
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1109411
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1109411
Global Stem Cell Therapy Market - Industry Trends and Forecast to 2029
PUBLISHED:
PAGES: 204 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
The global stem cell therapy market is projected to register a substantial CAGR of 9.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029
Market Segmentation:
Global Stem Cell Therapy Market, Product Type (Bone Marrow Derived Mesenchymal Cells, Placental or Umbilical Stem Cell, Adipose Tissue Derived Mesenchymal Stem Cells, and Others), Type (Allogenic Stem Cell Therapy and Autologous Stem Cell Therapy), Application (Musculoskeletal Disorders, Acute Graft-Versus-Host Disease (AGVHD), Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others), End User (Hospitals and Surgical Centers, Therapeutic Companies, Services Companies, and Others), Distribution Channel (Direct Tender, Third Party Distributors), Country (U.S., Canada, Italy, Belgium, Czech Republic, Germany, U.K., Spain, Hungary, Poland, South Korea, Japan and India, and Israel) Industry Trends and Forecast to 2029.
Some of the major factors contributing to the growth of the global stem cell therapy market are:
The rise in prevalence and incidence of chronic diseases
High investments in research and development
Market Players:
Some of the major players operating in the global stem cell therapy market are:
Osiris Therapeutics, Inc. (A subsidiary of Smith+Nephew)
JCR Pharmaceuticals Co., Ltd
Orthofix Medical Inc.
MEDIPOST
Takeda Pharmaceutical Company Limited
CORESTEM, Inc.
PHARMICELL Co., Ltd.
STEMPEUTICS RESEARCH PVT LTD
ANTEROGEN.CO., LTD
Holostem Terapie Avanzate S.r.l.
U.S. Stem Cell, Inc
BrainStorm Cell Limited
Pluristem Inc.
International Stem Cell Corporation
Mesoblast Ltd
Athersys, Inc.
BioRestorative Therapies, Inc.
TABLE OF CONTENTS
1 INTRODUCTION 20
- 1.1 OBJECTIVES OF THE STUDY 20
- 1.2 MARKET DEFINITION 20
- 1.3 OVERVIEW OF THE GLOBAL STEM CELL THERAPY MARKET 21
- 1.4 CURRENCY AND PRICING 23
- 1.5 LIMITATIONS 23
- 1.6 MARKETS COVERED 23
2 GLOBAL STEM CELL THERAPY MARKET: SEGMENTATION 25
- 2.1 MARKETS COVERED 25
- 2.2 GEOGRAPHICAL SCOPE 26
- 2.3 YEARS CONSIDERED FOR THE STUDY 27
- 2.4 DBMR TRIPOD DATA VALIDATION MODEL 28
- 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
- 2.6 MULTIVARIATE MODELLING 32
- 2.7 PRODUCT SEGMENT LIFELINE CURVE 32
- 2.8 DBMR MARKET POSITION GRID 33
- 2.9 VENDOR SHARE ANALYSIS 35
- 2.10 MARKET END USER COVERAGE GRID 36
- 2.11 SECONDARY SOURCES 37
3 EXECUTIVE SUMMARY 38
4 PREMIUM INSIGHTS 42
- 4.1 PESTEL 44
- 4.2 PORTER'S FIVE FORCES MODEL 45
5 EPIDEMIOLOGY 46
6 PIPELINE ANALYSIS FOR THE GLOBAL STEM CELL THERAPY MARKET 47
7 GLOBAL STEM CELL THERAPY MARKET: REGULATIONS 48
8 MARKET OVERVIEW 51
- 8.1 DRIVERS 53
- 8.1.1 THE RISE IN PREVALENCE AND INCIDENCE OF CHRONIC DISEASES 53
- 8.1.2 RISE IN INVESTMENT IN RESEARCH AND DEVELOPMENT AND AVAILABILITY OF FUNDING FOR STEM CELL RESEARCH 54
- 8.1.3 GROWING BIOTECHNOLOGY SECTOR 55
- 8.1.4 RISE IN GMP CERTIFICATION APPROVALS FOR CELL THERAPY PRODUCTION FACILITIES 56
- 8.1.5 RISE IN CLINICAL TRIALS FOR STEM-CELL-BASED THERAPIES 56
- 8.2 RESTRAINTS 57
- 8.2.1 THE RISE IN COST OF STEM-CELL-BASED THERAPY RESEARCH 57
- 8.2.2 THE RISKS FACED WHILE UNDERGOING STEM CELL THERAPY 57
- 8.2.3 ETHICAL CONCERNS RELATED TO STEM CELL THERAPY RESEARCH 58
- 8.2.4 AVAILABILITY OF ALTERNATIVES 58
- 8.3 OPPORTUNITIES 58
- 8.3.1 STRATEGIC INITIATIVE BY MARKET PLAYERS 58
- 8.3.2 RISE IN HEALTHCARE EXPENDITURE 59
- 8.3.3 THE EMERGENCE OF INDUCED PLURIPOTENT STEM CELLS (IPSCS) 60
- 8.4 CHALLENGES 60
- 8.4.1 THE LACK OF SKILLED PROFESSIONALS REQUIRED FOR STEM CELL THERAPY 60
- 8.4.2 STRINGENT REGULATIONS 61
9 GLOBAL STEM CELL THERAPY MARKET, BY PRODUCT TYPE 63
- 9.1 OVERVIEW 64
- 9.2 BONE MARROW DERIVED MESENCHYMAL STEM CELLS 67
- 9.3 PLACENTAL/UMBILICAL STEM CELL 67
- 9.4 ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS 68
- 9.5 OTHERS 69
10 GLOBAL STEM CELL THERAPY MARKET, BY TYPE 71
- 10.1 OVERVIEW 72
- 10.2 ALLOGENEIC STEM CELL THERAPY 75
- 10.2.1 MUSCULOSKELETAL DISORDERS 76
- 10.2.2 WOUNDS AND INJURIES 76
- 10.2.3 ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) 76
- 10.2.4 SURGERIES 76
- 10.2.5 GASTROINTESTINAL DISEASES 76
- 10.2.6 OTHER APPLICATION 76
- 10.3 AUTOLOGOUS STEM CELL THERAPY 76
- 10.3.1 CARDIOVASCULAR DISEASES 78
- 10.3.2 GASTROINTESTINAL DISEASES 78
- 10.3.3 OTHER APPLICATION 78
11 GLOBAL STEM CELL THERAPY MARKET, BY APPLICATION 79
- 11.1 OVERVIEW 80
- 11.2 MUSCULOSKELETAL DISORDERS 82
- 11.3 WOUNDS AND INJURIES 83
- 11.4 ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) 84
- 11.5 SURGERIES 85
- 11.6 GASTROINTESTINAL DISEASES 86
- 11.7 CARDIOVASCULAR DISEASES 86
- 11.8 OTHER APPLICATION 87
12 GLOBAL STEM CELL THERAPY MARKET, BY END USER 89
- 12.1 OVERVIEW 90
- 12.2 HOSPITAL AND SURGICAL CENTERS 93
- 12.3 THERAPEUTIC COMPANIES 93
- 12.4 SERVICES COMPANIES 94
- 12.5 OTHERS 95
13 GLOBAL STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL 96
- 13.1 OVERVIEW 97
- 13.2 DIRECT TENDER 101
- 13.3 THIRD PARTY DISTRIBUTORS 101
14 GLOBAL STEM CELL THERAPY MARKET, BY REGION 103
- 14.1 OVERVIEW 104
- 14.2 NORTH AMERICA 109
- 14.2.1 U.S. 115
- 14.2.2 CANADA 117
- 14.3 ASIA-PACIFIC 119
- 14.3.1 SOUTH KOREA 125
- 14.3.2 JAPAN 127
- 14.3.3 INDIA 129
- 14.4 EUROPE 131
- 14.4.1 ITALY 137
- 14.4.2 BELGIUM 139
- 14.4.3 CZECH REPUBLIC 141
- 14.4.4 GERMANY 143
- 14.4.5 U.K. 145
- 14.4.6 SPAIN 147
- 14.4.7 HUNGARY 149
- 14.4.8 POLAND 151
- 14.5 MIDDLE EAST AND AFRICA 153
- 14.5.1 ISRAEL 159
- 14.6 SOUTH AMERICA 161
15 GLOBAL STEM CELL THERAPY MARKET: COMPANY LANDSCAPE 162
- 15.1 COMPANY SHARE ANALYSIS: GLOBAL 162
- 15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 163
- 15.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 164
- 15.4 COMPANY SHARE ANALYSIS: EUROPE 165
16 SWOT ANALYSIS 166
17 COMPANY PROFILE 167
- 17.1 OSIRIS THERAPEUTICS, INC. (A SUBSIDIARY OF SMITH+NEPHEW) (2021) 167
- 17.1.1 COMPANY SNAPSHOT 167
- 17.1.2 REVENUE ANALYSIS 167
- 17.1.3 COMPANY SHARE ANALYSIS 168
- 17.1.4 PRODUCT PORTFOLIO 168
- 17.1.5 RECENT DEVELOPMENT 168
- 17.2 JCR PHARMACEUTICALS CO., LTD ( (2021) 169
- 17.2.1 COMPANY SNAPSHOT 169
- 17.2.2 REVENUE ANALYSIS 169
- 17.2.3 COMPANY SHARE ANALYSIS 170
- 17.2.4 PRODUCT PORTFOLIO 170
- 17.2.5 RECENT DEVELOPMENTS 170
- 17.3 ORTHOFIX MEDICAL INC. (2021) 171
- 17.3.1 COMPANY SNAPSHOT 171
- 17.3.2 REVENUE ANALYSIS 171
- 17.3.3 COMPANY SHARE ANALYSIS 172
- 17.3.4 PRODUCT PORTFOLIO 172
- 17.3.5 RECENT DEVELOPMENTS 172
- 17.4 MEDIPOST (2021) 174
- 17.4.1 COMPANY SNAPSHOT 174
- 17.4.2 REVENUE ANALYSIS 174
- 17.4.3 COMPANY SHARE ANALYSIS 175
- 17.4.4 PRODUCT PORTFOLIO 175
- 17.4.5 RECENT DEVELOPMENTS 175
- 17.5 TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021) 177
- 17.5.1 COMPANY SNAPSHOT 177
- 17.5.2 REVENUE ANALYSIS 177
- 17.5.3 COMPANY SHARE ANALYSIS 178
- 17.5.4 PRODUCT PORTFOLIO 178
- 17.5.5 RECENT DEVELOPMENT 178
- 17.6 CORESTEM, INC. (2021) 179
- 17.6.1 COMPANY SNAPSHOT 179
- 17.6.2 REVENUE ANALYSIS 179
- 17.6.3 PRODUCT PORTFOLIO 180
- 17.6.4 RECENT DEVELOPMENT 180
- 17.7 PHARMICELL CO., LTD. (2021) 181
- 17.7.1 COMPANY SNAPSHOT 181
- 17.7.2 PRODUCT PORTFOLIO 181
- 17.7.3 RECENT DEVELOPMENTS 181
- 17.8 ANTEROGEN.CO., LTD (2021) 182
- 17.8.1 COMPANY SNAPSHOT 182
- 17.8.2 PRODUCT PORTFOLIO 182
- 17.8.3 RECENT DEVELOPMENTS 182
- 17.9 ATHERSYS, INC.(2021) 183
- 17.9.1 COMPANY SNAPSHOT 183
- 17.9.2 REVENUE ANALYSIS 183
- 17.9.3 PRODUCT PORTFOLIO 184
- 17.9.4 RECENT DEVELOPMENTS 184
- 17.10 BRAINSTORM CELL LIMITED (2021) 185
- 17.10.1 COMPANY SNAPSHOT 185
- 17.10.2 PRODUCT PORTFOLIO 185
- 17.10.3 RECENT DEVELOPMENTS 185
- 17.11 BIORESTORATIVE THERAPIES, INC. (2021) 187
- 17.11.1 COMPANY SNAPSHOT 187
- 17.11.2 REVENUE ANALYSIS 187
- 17.11.3 PRODUCT PORTFOLIO 188
- 17.11.4 RECENT DEVELOPMENTS 188
- 17.12 HOLOSTEM TERAPIE AVANZATE S.R.L. (2021) 189
- 17.12.1 COMPANY SNAPSHOT 189
- 17.12.2 PRODUCT PORTFOLIO 189
- 17.12.3 RECENT DEVELOPMENTS 189
- 17.13 INTERNATIONAL STEMCELL CORPORATION (2021) 191
- 17.13.1 COMPANY SNAPSHOT 191
- 17.13.2 REVENUE ANALYSIS 191
- 17.13.3 PRODUCT PORTFOLIO 192
- 17.13.4 RECENT DEVELOPMENT 192
- 17.14 MESOBLAST LTD (2021) 193
- 17.14.1 COMPANY SNAPSHOT 193
- 17.14.2 REVENUE ANALYSIS 193
- 17.14.3 PRODUCT PORTFOLIO 194
- 17.14.4 RECENT DEVELOPMENTS 194
- 17.15 PLURISTEM INC.(2021) 195
- 17.15.1 COMPANY SNAPSHOT 195
- 17.15.2 REVENUE ANALYSIS 195
- 17.15.3 PRODUCT PORTFOLIO 196
- 17.15.4 RECENT DEVELOPMENT 196
- 17.16 STEMPEUTICS RESEARCH PVT LTD 197
- 17.16.1 COMPANY SNAPSHOT 197
- 17.16.2 PRODUCT PORTFOLIO 197
- 17.16.3 RECENT DEVELOPMENTS 197
- 17.17 U.S. STEM CELL, INC. (2021) 199
- 17.17.1 COMPANY SNAPSHOT 199
- 17.17.2 REVENUE ANALYSIS 199
- 17.17.3 PRODUCT PORTFOLIO 200
- 17.17.4 RECENT DEVELOPMENT 200
18 QUESTIONNAIRE 201
19 RELATED REPORTS 204
LIST OF TABLES
- TABLE 1 GLOBAL STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 66
- TABLE 2 GLOBAL BONE MARROW DERIVED MESENCHYMAL STEM CELLS IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 67
- TABLE 3 GLOBAL PLACENTAL/UMBILICAL STEM CELL IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 68
- TABLE 4 GLOBAL ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 69
- TABLE 5 GLOBAL OTHERS IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 70
- TABLE 6 GLOBAL STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 74
- TABLE 7 GLOBAL ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 75
- TABLE 8 GLOBAL ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 76
- TABLE 9 GLOBAL AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 77
- TABLE 10 GLOBAL AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 77
- TABLE 11 GLOBAL STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 82
- TABLE 12 GLOBAL MUSCULOSKELETAL DISORDERS IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 83
- TABLE 13 GLOBAL WOUNDS AND INJURIES IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 84
- TABLE 14 GLOBAL ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 85
- TABLE 15 GLOBAL SURGERIES IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 85
- TABLE 16 GLOBAL GASTROINTESTINAL DISEASES IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 86
- TABLE 17 GLOBAL CARDIOVASCULAR DISEASES IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 87
- TABLE 18 GLOBAL OTHER APPLICATION IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 88
- TABLE 19 GLOBAL STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 92
- TABLE 20 GLOBAL HOSPITAL AND SURGICAL CENTERS IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 93
- TABLE 21 GLOBAL THERAPEUTIC COMPANIES IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 94
- TABLE 22 GLOBAL SERVICES COMPANIES IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 95
- TABLE 23 GLOBAL OTHERS IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 95
- TABLE 24 GLOBAL STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 100
- TABLE 25 GLOBAL DIRECT TENDER IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 101
- TABLE 26 GLOBAL THIRD PARTY DISTRIBUTORS IN STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 102
- TABLE 27 GLOBAL STEM CELL THERAPY MARKET, BY REGION, 2020-2029 (USD MILLION) 108
- TABLE 28 NORTH AMERICA STEM CELL THERAPY MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 113
- TABLE 29 NORTH AMERICA STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 113
- TABLE 30 NORTH AMERICA STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 113
- TABLE 31 NORTH AMERICA ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 113
- TABLE 32 NORTH AMERICA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 114
- TABLE 33 NORTH AMERICA STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 114
- TABLE 34 NORTH AMERICA STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 114
- TABLE 35 NORTH AMERICA STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 114
- TABLE 36 U.S. STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 115
- TABLE 37 U.S. STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 115
- TABLE 38 U.S. ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 115
- TABLE 39 U.S. AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 115
- TABLE 40 U.S. STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 116
- TABLE 41 U.S. STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 116
- TABLE 42 U.S. STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 116
- TABLE 43 CANADA STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 117
- TABLE 44 CANADA STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 117
- TABLE 45 CANADA ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 117
- TABLE 46 CANADA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 117
- TABLE 47 CANADA STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 118
- TABLE 48 CANADA STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 118
- TABLE 49 CANADA STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 118
- TABLE 50 SIA-PACIFIC STEM CELL THERAPY MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 123
- TABLE 51 ASIA-PACIFIC STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 123
- TABLE 52 ASIA-PACIFIC STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 123
- TABLE 53 ASIA-PACIFIC ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 123
- TABLE 54 ASIA-PACIFIC AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 124
- TABLE 55 ASIA-PACIFIC STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 124
- TABLE 56 ASIA-PACIFIC STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 124
- TABLE 57 ASIA-PACIFIC STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 124
- TABLE 58 SOUTH KOREA STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 125
- TABLE 59 SOUTH KOREA STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 125
- TABLE 60 SOUTH KOREA ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 125
- TABLE 61 SOUTH KOREA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 125
- TABLE 62 SOUTH KOREA STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 126
- TABLE 63 SOUTH KOREA STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 126
- TABLE 64 SOUTH KOREA STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 126
- TABLE 65 JAPAN STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 127
- TABLE 66 JAPAN STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 127
- TABLE 67 JAPAN ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 127
- TABLE 68 JAPAN AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 127
- TABLE 69 JAPAN STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 128
- TABLE 70 JAPAN STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 128
- TABLE 71 JAPAN STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 128
- TABLE 72 INDIA STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 129
- TABLE 73 INDIA STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 129
- TABLE 74 INDIA ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 129
- TABLE 75 INDIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 129
- TABLE 76 INDIA STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 130
- TABLE 77 INDIA STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 130
- TABLE 78 INDIA STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 130
- TABLE 79 EUROPE STEM CELL THERAPY MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 135
- TABLE 80 EUROPE STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 135
- TABLE 81 EUROPE STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 135
- TABLE 82 EUROPE ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 135
- TABLE 83 EUROPE AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 136
- TABLE 84 EUROPE STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 136
- TABLE 85 EUROPE STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 136
- TABLE 86 EUROPE STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 136
- TABLE 87 ITALY STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 137
- TABLE 88 ITALY STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 137
- TABLE 89 ITALY ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 137
- TABLE 90 ITALY AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 137
- TABLE 91 ITALY STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 138
- TABLE 92 ITALY STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 138
- TABLE 93 ITALY STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 138
- TABLE 94 BELGIUM STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 139
- TABLE 95 BELGIUM STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 139
- TABLE 96 BELGIUM ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 139
- TABLE 97 BELGIUM AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 139
- TABLE 98 \BELGIUM STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 140
- TABLE 99 BELGIUM STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 140
- TABLE 100 BELGIUM STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 140
- TABLE 101 CZECH REPUBLIC STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 141
- TABLE 102 CZECH REPUBLIC STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 141
- TABLE 103 CZECH REPUBLIC ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 141
- TABLE 104 CZECH REPUBLIC AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 141
- TABLE 105 CZECH REPUBLIC STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 142
- TABLE 106 CZECH REPUBLIC STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 142
- TABLE 107 CZECH REPUBLIC STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 142
- TABLE 108 GERMANY STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 143
- TABLE 109 GERMANY STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 143
- TABLE 110 GERMANY ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 143
- TABLE 111 GERMANY AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 143
- TABLE 112 GERMANY STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 144
- TABLE 113 GERMANY STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 144
- TABLE 114 GERMANY STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 144
- TABLE 115 U.K. STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 145
- TABLE 116 U.K. STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 145
- TABLE 117 U.K. ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 145
- TABLE 118 U.K. AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 145
- TABLE 119 U.K. STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 146
- TABLE 120 U.K. STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 146
- TABLE 121 U.K. STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 146
- TABLE 122 SPAIN STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 147
- TABLE 123 SPAIN STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 147
- TABLE 124 SPAIN ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 147
- TABLE 125 SPAIN AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 147
- TABLE 126 SPAIN STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 148
- TABLE 127 SPAIN STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 148
- TABLE 128 SPAIN STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 148
- TABLE 129 HUNGARY STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 149
- TABLE 130 HUNGARY STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 149
- TABLE 131 HUNGARY ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 149
- TABLE 132 HUNGARY AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 149
- TABLE 133 HUNGARY STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 150
- TABLE 134 HUNGARY STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 150
- TABLE 135 HUNGARY STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 150
- TABLE 136 POLAND STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 151
- TABLE 137 POLAND STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 151
- TABLE 138 POLAND ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 151
- TABLE 139 POLAND AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 151
- TABLE 140 POLAND STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 152
- TABLE 141 POLAND STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 152
- TABLE 142 POLAND STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 152
- TABLE 143 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 157
- TABLE 144 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 157
- TABLE 145 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 157
- TABLE 146 MIDDLE EAST AND AFRICA ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 157
- TABLE 147 MIDDLE EAST AND AFRICA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 158
- TABLE 148 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 158
- TABLE 149 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 158
- TABLE 150 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 158
- TABLE 151 ISRAEL STEM CELL THERAPY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 159
- TABLE 152 ISRAEL STEM CELL THERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION) 159
- TABLE 153 ISRAEL ALLOGENEIC STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 159
- TABLE 154 ISRAEL AUTOLOGOUS STEM CELL THERAPY IN STEM CELL THERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 159
- TABLE 155 ISRAEL STEM CELL THERAPY MARKET, BY APPLICATIONS, 2020-2029 (USD MILLION) 160
- TABLE 156 ISRAEL STEM CELL THERAPY MARKET, BY END USER, 2020-2029 (USD MILLION) 160
- TABLE 157 ISRAEL STEM CELL THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 160
LIST OF FIGURES
- FIGURE 1 GLOBAL STEM CELL THERAPY MARKET : SEGMENTATION 25
- FIGURE 2 GLOBAL STEM CELL THERAPY MARKET: DATA TRIANGULATION 28
- FIGURE 3 GLOBAL STEM CELL THERAPY MARKET: DROC ANALYSIS 29
- FIGURE 4 GLOBAL STEM CELL THERAPY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 30
- FIGURE 5 GLOBAL STEM CELL THERAPY MARKET: COMPANY RESEARCH ANALYSIS 30
- FIGURE 6 GLOBAL STEM CELL THERAPY MARKET: INTERVIEW DEMOGRAPHICS 31
- FIGURE 7 GLOBAL STEM CELL THERAPY MARKET: DBMR POSITION GRID 33
- FIGURE 8 GLOBAL STEM CELL THERAPY MARKET: VENDOR SHARE ANALYSIS 35
- FIGURE 9 GLOBAL STEM CELL THERAPY MARKET: END USER COVERAGE GRID 36
- FIGURE 10 GLOBAL STEM CELL THERAPY MARKET: SEGMENTATION 40
- FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL STEM CELL THERAPY MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029 41
- FIGURE 12 INCREASED INCIDENCE OF CHRONIC DISEASES, RISE IN CLINICAL TRIALS, GMP CERTIFICATION AND PRODUCT APPPROVALS IS EXPECTED TO DRIVE THE GLOBAL STEM CELL THERAPY MARKET FROM 2022 TO 2029 42
- FIGURE 13 PRODUCT TYPE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE GLOBAL STEM CELL THERAPY MARKET FROM 2022 & 2029 42
- FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR FOR INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MANUFACTURERS IN THE FORECAST PERIOD OF 2022 TO 2029 43
- FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL STEM CELL THERAPY MARKET 52
- FIGURE 16 NUMBER AND AGES OF PEOPLE 65 OR OLDER WITH ALZHEIMER'S DEMENTIA IN 2022 53
- FIGURE 17 INCIDENCE OF VARIOUS TYPES OF CANCER IN 2020 54
- FIGURE 18 GLOBAL STEM CELL THERAPY MARKET: BY PRODUCT TYPE, 2021 64
- FIGURE 19 GLOBAL STEM CELL THERAPY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION) 65
- FIGURE 20 GLOBAL STEM CELL THERAPY MARKET: BY PRODUCT TYPE, CAGR (2022-2029) 65
- FIGURE 21 GLOBAL STEM CELL THERAPY MARKET: BY PRODUCT TYPE, LIFELINE CURVE 66
- FIGURE 22 GLOBAL STEM CELL THERAPY MARKET: BY TYPE, 2021 72
- FIGURE 23 GLOBAL STEM CELL THERAPY MARKET: BY TYPE, 2022-2029 (USD MILLION) 73
- FIGURE 24 GLOBAL STEM CELL THERAPY MARKET: BY TYPE, CAGR (2022-2029) 73
- FIGURE 25 GLOBAL STEM CELL THERAPY MARKET: BY TYPE, LIFELINE CURVE 74
- FIGURE 26 GLOBAL STEM CELL THERAPY MARKET: BY APPLICATION, 2021 80
- FIGURE 27 GLOBAL STEM CELL THERAPY MARKET: BY APPLICATION, 2022-2029 (USD MILLION) 81
- FIGURE 28 GLOBAL STEM CELL THERAPY MARKET: BY APPLICATION, CAGR (2022-2029) 81
- FIGURE 29 GLOBAL STEM CELL THERAPY MARKET: BY APPLICATION, LIFELINE CURVE 82
- FIGURE 30 GLOBAL STEM CELL THERAPY MARKET: BY END USER, 2021 90
- FIGURE 31 GLOBAL STEM CELL THERAPY MARKET: BY END USER, 2022-2029 (USD MILLION) 91
- FIGURE 32 GLOBAL STEM CELL THERAPY MARKET: BY END USER, CAGR (2022-2029) 91
- FIGURE 33 GLOBAL STEM CELL THERAPY MARKET: BY END USER, LIFELINE CURVE 92
- FIGURE 34 GLOBAL STEM CELL THERAPY MARKET: BY DISTRIBUTION CHANNEL, 2021 98
- FIGURE 35 GLOBAL STEM CELL THERAPY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 99
- FIGURE 36 GLOBAL STEM CELL THERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 99
- FIGURE 37 GLOBAL STEM CELL THERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 100
- FIGURE 38 GLOBAL STEM CELL THERAPY MARKET: SNAPSHOT (2021) 105
- FIGURE 39 GLOBAL STEM CELL THERAPY MARKET: BY REGION (2021) 106
- FIGURE 40 GLOBAL STEM CELL THERAPY MARKET: BY REGION (2022 & 2029) 106
- FIGURE 41 GLOBAL STEM CELL THERAPY MARKET: BY REGION (2021 & 2029) 107
- FIGURE 42 GLOBAL STEM CELL THERAPY MARKET: BY PRODUCT TYPE (2022-2029) 107
- FIGURE 43 NORTH AMERICA STEM CELL THERAPY MARKET: SNAPSHOT (2021) 110
- FIGURE 44 NORTH AMERICA STEM CELL THERAPY MARKET: BY COUNTRY (2021) 111
- FIGURE 45 NORTH AMERICA STEM CELL THERAPY MARKET: BY COUNTRY (2022 & 2029) 111
- FIGURE 46 NORTH AMERICA STEM CELL THERAPY MARKET: BY COUNTRY (2021 & 2029) 112
- FIGURE 47 NORTH AMERICA STEM CELL THERAPY MARKET: BY PRODUCT TYPE (2022-2029) 112
- FIGURE 48 ASIA-PACIFIC STEM CELL THERAPY MARKET: SNAPSHOT (2021) 120
- FIGURE 49 ASIA-PACIFIC STEM CELL THERAPY MARKET: BY COUNTRY (2021) 121
- FIGURE 50 ASIA-PACIFIC STEM CELL THERAPY MARKET: BY COUNTRY (2022 & 2029) 121
- FIGURE 51 ASIA-PACIFIC STEM CELL THERAPY MARKET: BY COUNTRY (2021 & 2029) 122
- FIGURE 52 ASIA-PACIFIC STEM CELL THERAPY MARKET: BY PRODUCT TYPE (2022 & 2029) 122
- FIGURE 53 EUROPE STEM CELL THERAPY MARKET: SNAPSHOT (2021) 132
- FIGURE 54 EUROPE STEM CELL THERAPY MARKET: BY COUNTRY (2021) 133
- FIGURE 55 EUROPE STEM CELL THERAPY MARKET: BY COUNTRY (2022 & 2029) 133
- FIGURE 56 EUROPE STEM CELL THERAPY MARKET: BY COUNTRY (2021 & 2029) 134
- FIGURE 57 EUROPE STEM CELL THERAPY MARKET: BY PRODUCT TYPE (2022 & 2029) 134
- FIGURE 58 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET: SNAPSHOT (2021) 154
- FIGURE 59 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET: BY COUNTRY (2021) 155
- FIGURE 60 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET: BY COUNTRY (2022 & 2029) 155
- FIGURE 61 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET: BY COUNTRY (2021 & 2029) 156
- FIGURE 62 MIDDLE EAST AND AFRICA STEM CELL THERAPY MARKET: BY PRODUCT TYPE (2022-2029) 156
- FIGURE 63 GLOBAL STEM CELL THERAPY MARKET: COMPANY SHARE 2021 (%) 162
- FIGURE 64 NORTH AMERICA STEM CELL THERAPY MARKET: COMPANY SHARE 2021 (%) 163
- FIGURE 65 ASIA-PACIFIC STEM CELL THERAPY MARKET: COMPANY SHARE 2021(%) 164
- FIGURE 66 EUROPE STEM CELL THERAPY MARKET: COMPANY SHARE 2021(%) 165
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.